When evaluating a patient diagnosed with non-small cell lung cancer (NSCLC), staging
helps define the extent of disease. The main goals of staging are to assist in determining …

Lung cancer is the leading cause of cancer deaths in men and women in the United States.
Accurate staging is needed to determine prognosis and devise effective treatment plans …

The International Association for the Study of Lung Cancer proposed changes to the 7th
edition of the Tumor, Node, and Metastasis (TNM) staging manual of non–small cell lung …

The stage of non-small cell lung cancer (NSCLC) determines that the treatment strategy and
proper staging lead to improved survival. Integrated positron emission tomography …

Preoperative tumor staging in patients with non-small-cell lung cancer is important for
selecting those patients with localized disease who are likely to benefit from surgical …

Today lung cancer remains the leading cause of cancer-related death in the United States,
accounting for 28% of all cases. Radiologists play an important role in the assessment of this …

This article is the second in a planned series from the Section on Cancer of the ACCP. The
first article (Little AG, Stitik FP: Clinical staging of patients with non-small cell lung cancer …

The revised TNM system proposed in 1997 had been widely accepted for staging of non-
small cell lung cancer (NSCLC). The tumor (T) and regional lymph node (N) stage …

Surgical resection offers the best chance of cure for patients with lung cancer. However, the
5-year survival after surgical resection is only between 25% and 40%, mainly due to tumour …

Accurate staging remains the cornerstone of initial managment of nonsmall cell lung cancer.
CT offers the potential advantage of identifying early stage tumors when broadly applied as …